Evidence map›Paper›PMID 20144219›Full record

ReviewCritical care (London, England)2010

Sepsis biomarkers: a review.

Charalampos Pierrakos, Jean-Louis Vincent

4 registry-linked trialsAbstract readReview
In one paragraph

Review in Critical care (London, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 606 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
606citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01747187 unknown statusnot on this mapstarted 2012, after this paper: background citation

Cardiac Stress in Septic Shock - Biomarkers, Echocardiography and Outcome.

TypeobservationalSponsorUniversity Hospital, LinkoepingRan2012 to 2015Enrolled50ConditionsSeptic Shock, Left Ventricular Systolic Dysfunction, Left Ventricular Diastolic Dysfunction
NCT03651635 completednot on this mapstarted 2018, after this paper: background citation

To Assess and Validate the Use of MR-proADM and the CT-proET-1/MR-proADM Ratio as Prognostic Markers During the First 7 Days of ICU Treat-ment

TypeobservationalSponsorUniversity of ZurichRan2018 to 2019Enrolled533ConditionsAcute Phase Biomarkers, Medical ICU Admitted PatientsArmsBlood sampling for MR-proADM & CT-proET-1
NCT04624945 unknown statusnot on this mapstarted 2020, after this paper: background citation

DetectIon of Severe Sepsis In PATients With Neurological haemorrhagE (The DISSIPATE Study)

TypeobservationalSponsorNational University Hospital, SingaporeRan2020 to 2024Enrolled150ConditionsSepsis, Hemorrhage BrainArmsAPTT CWA (Activated partial thromboplastin time clot waveform analysis), Procalcitonin and Serological/Inflammatory markers (KL-6, SPA, MIG, Presepsin)
NCT07248527 active not recruitingnot on this mapstarted 2025, after this paper: background citation

PAN-ICIS: Prospective Observational Study Evaluating the Intensive Care Infection Score for Early Detection of Infectious Complications After Pancreatic Resections

TypeobservationalSponsorCharles University, Czech RepublicRan2025 to 2028Enrolled400ConditionsPancreatectomy, Pancreatic Surgery, Intensive Care (ICU), Inflamatory Markers
3 · Its place in the literature

Who cites it

606 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

546 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Charalampos PierrakosDepartment of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, route de Lennik 808, 1070 Brussels, Belgium. charalampos_p@hotmail.com
Jean-Louis Vincent

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBiomarkers can be useful for identifying or ruling out sepsis, identifying patients who may benefit from specific therapies or assessing the response to therapy.

methodsWe used an electronic search of the PubMed database using the key words "sepsis" and "biomarker" to identify clinical and experimental studies which evaluated a biomarker in sepsis.

resultsThe search retrieved 3370 references covering 178 different biomarkers.

conclusionsMany biomarkers have been evaluated for use in sepsis. Most of the biomarkers had been tested clinically, primarily as prognostic markers in sepsis; relatively few have been used for diagnosis. None has sufficient specificity or sensitivity to be routinely employed in clinical practice. PCT and CRP have been most widely used, but even these have limited ability to distinguish sepsis from other inflammatory conditions or to predict outcome.

Indexed as

BiomarkersHumansSepsisBiomarkers

Identifiers

PMID20144219
PMCPMC2875530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.